CCP grants exemptions to logistics and transport sector
The Competition Commission of Pakistan (CCP) has granted two conditional exemptions to undertakings in the transport and logistics sector, permitting limited restrictive provisions under joint venture agreements aimed at strengthening Pakistan's logistics capabilities.
According to a press statement released on Monday, the exemptions were approved following a comprehensive review by CCP's Exemptions Department, which assessed the legal framework, potential market impact, and the long-term investment plans associated with the proposed collaborations.
'These arrangements were found to satisfy the requirements set out in Section 9 of the Competition Act, 2010. The joint ventures are expected to foster technical progress, enhance operational efficiency, and improve service standards in the logistics and freight sectors,' read the statement.
CCP grants six exemptions to pharma sector
CCP observed that the joint ventures will leverage international best practices alongside local expertise, contributing to infrastructure development, innovation, and greater consumer value.
Specific provisions within the shareholders' agreements—such as non-compete and exclusivity clauses—were conditionally approved to ensure investment protection and coordination, while safeguarding against risks of market foreclosure.
These approvals reaffirm CCP's commitment to facilitating strategic business collaboration that supports economic growth, while ensuring that competition remains open, fair, and free from abuse of dominance, said CCP.
'All exemptions are subject to strict compliance with conditions designed to preserve competitive dynamics in the market,' read the statement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
4 days ago
- Business Recorder
CAT upholds CCP decision against PSM
ISLAMABAD: The Competition Appellate Tribunal (CAT) has upheld the Competition Commission of Pakistan (CCP) decision against Pakistan Steel Mills (PSM), affirming its ruling that the state-owned enterprise had abused its dominant position in the sale of low carbon steel billets. The CCP had imposed a penalty of Rs25 million for PSM's anti-competitive and discriminatory conduct. While acknowledging the violation, the Tribunal partially allowed PSM's appeal and reduced the penalty to Rs5 million, citing the limited duration of non-compliance. The CCP took suo motu notice in 2009 following media reports and a complaint by M/s Frontier Foundry (Pvt.) Ltd., which alleged preferential treatment by PSM towards a particular buyer, Abbas Group, at the expense of other market participants. CCP's investigation revealed that PSM withheld supply of key steel products between November 2008 and January 2009 without any objective justification, thereby violating Section 3 of the Competition Ordinance, 2007. The Tribunal observed that PSM failed to inform all buyers of product availability, enabling exclusive access for a single group and causing harm to other market players. Such conduct, the Tribunal noted, constituted abuse of dominance under Section 3(2)(g) and (h) of the Ordinance. Copyright Business Recorder, 2025
Express Tribune
4 days ago
- Express Tribune
Tribunal reduces penalty on steel mill
To resolve the issue, the company even offered to transfer 15% (126 million) shares of the steel mill to the government without any payment in exchange for gas supply. photo: file Listen to article The Competition Appellate Tribunal has upheld the Competition Commission of Pakistan's (CCP) decision against Pakistan Steel Mills (PSM), affirming its ruling that the state-owned enterprise abused its dominant position in the sale of low-carbon steel billets. The CCP had imposed a penalty of Rs25 million for PSM's anti-competitive and discriminatory conduct. While acknowledging the violation, the tribunal partially allowed PSM's appeal and reduced the penalty to Rs5 million, citing the limited duration of non-compliance. The CCP took suo motu notice in 2009 following media reports and a complaint from Frontier Foundry that alleged preferential treatment by PSM towards a particular buyer, Abbas Group, at the expense of other market participants. The CCP investigation revealed that PSM withheld supply of key steel products between November 2008 and January 2009 without any objective justification, violating Section 3 of the Competition Ordinance.
Business Recorder
14-06-2025
- Business Recorder
CAT upholds CCP decision, confirms pharma co misled hospitals by false marketing
ISLAMABAD: The Competition Appellate Tribunal (CAT) has upheld a significant decision by the Competition Commission of Pakistan (CCP), confirming that a pharmaceutical company misled hospitals by falsely marketing a life-saving product for kidney patients. The Tribunal dismissed the appeal of 3N LIFEMED Pharmaceuticals and endorsed the Commission's finding of deceptive marketing—though it reduced the monetary penalty from Rs20 million to Rs2 million. The CCP had received a formal complaint from M/s Renacon Pharma Limited, which accused 3N LIFEMED of using fake quality certifications to market Haemodialysis Concentrate, a crucial product used in the treatment of kidney failure. The CCP's investigation revealed that 3N LIFEMED had falsely claimed its product was certified with Conformité Européene (CE) and Quality Management System (QMS) marks, obtained from a non-accredited firm based in Islamabad. These certifications, although voluntary under Pakistani laws, are widely seen as benchmarks of quality and are often required in public procurement tenders. The misleading claims were found to have misinformed hospitals and patients, creating a false impression of superior safety and efficacy in a sensitive market segment. Haemodialysis Concentrate is classified as a medical device by the Drug Regulatory Authority of Pakistan (DRAP) and is used to create dialysis fluid, which must closely match the patient's natural blood chemistry to prevent complications. During the CAT proceedings, 3N LIFEMED's counsel argued that the company ceased using the disputed markings after receiving a show-cause notice from CCP and insisted that the product was DRAP-approved. They also attempted to shift blame to SIMS-AGS, the Islamabad-based company that issued the certifications, whose international accreditation was revoked in 2020. However, CCP's counsel countered that 3N LIFEMED, as a pharmaceutical company, should have known that such certifications cannot simply be purchased but must be earned through rigorous inspections. The Tribunal agreed with CCP's position, observing that while such certifications may not be legally mandatory, they influence procurement decisions and public trust—and misusing them constitutes deception. In light of 3N LIFEMED's financial capacity, the Tribunal reduced the penalty to Rs2 million but imposed a strict compliance deadline: failure to pay within ten days will attract an additional fine of Rs100,000 per day. Copyright Business Recorder, 2025
